XML 102 R21.htm IDEA: XBRL DOCUMENT
v3.20.1

Business Segment Information | 6 Months Ended
--- | ---
Apr. 30, 2020
Segment Reporting [Abstract] |
Business Segment Information | Business Segment Information The Company discloses information about its operating segments, which were established based on the way that management organizes segments within the Company for making operating decisions and assessing financial performance. The Company's two operating segments are described below.
• | CooperVision. Competes in the worldwide contact lens market by developing, manufacturing and marketing a broad range of products for contact lens wearers, featuring advanced materials and optics. CooperVision designs its products to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues, with a broad collection of spherical, toric and multifocal contact lenses.
• | CooperSurgical. Competes in the general health care market with a focus on advancing the health of women, babies and families through a diversified portfolio of products and services focusing on women's health, fertility, diagnostics and contraception.
Cooper uses operating income, as presented in our financial reports, as the primary measure of segment profitability. We do not allocate costs from corporate functions to segment operating income. Items below operating income are not considered when measuring the profitability of a segment. We use the same accounting policies to generate segment results as we do for our consolidated results. Total identifiable assets are those used in continuing operations except cash and cash equivalents, which we include as corporate assets. Segment information:
Periods Ended April 30, | Three Months |  | Six Months
(In millions) | 2020 |  | 2019 |  | 2020 |  | 2019
CooperVision net sales by category: |  |  |  |  |  |  |
Toric lens | $ | 133.6 |  |  | $ | 155.3 |  |  | $ | 288.7 |  |  | $ | 301.3 |
Multifocal lens | 45.1 |  |  | 49.7 |  |  | 96.9 |  |  | 98.7 |
Single-use sphere lens | 116.1 |  |  | 135.3 |  |  | 254.2 |  |  | 267.3 |
Non single-use sphere, other | 107.4 |  |  | 143.9 |  |  | 247.6 |  |  | 287.0 |
Total CooperVision net sales | $ | 402.2 |  |  | $ | 484.2 |  |  | 887.4 |  |  | 954.3 |
CooperSurgical net sales by category: |  |  |  |  |  |  |
Office and surgical products | 69.6 |  |  | 105.7 |  |  | 168.0 |  |  | 201.4 |
Fertility | 53.1 |  |  | 64.4 |  |  | 115.7 |  |  | 126.7 |
CooperSurgical net sales | 122.7 |  |  | 170.1 |  |  | 283.7 |  |  | 328.1 |
Total net sales | $ | 524.9 |  |  | $ | 654.3 |  |  | $ | 1,171.1 |  |  | $ | 1,282.4 |
Operating income: |  |  |  |  |  |  |
CooperVision | $ | 67.7 |  |  | $ | 125.5 |  |  | $ | 190.6 |  |  | $ | 241.7 |
CooperSurgical | (25.6 | ) |  | 31.1 |  |  | (23.9 | ) |  | 38.3 |
Corporate | (13.5 | ) |  | (9.7 | ) |  | (27.0 | ) |  | (22.2 | )
Total operating income | 28.6 |  |  | 146.9 |  |  | 139.7 |  |  | 257.8 |
Interest expense | 12.8 |  |  | 18.5 |  |  | 24.4 |  |  | 36.6 |
Other expense (income), net | 6.8 |  |  | 0.3 |  |  | 8.9 |  |  | (0.7 | )
Income before income taxes | $ | 9.0 |  |  | $ | 128.1 |  |  | $ | 106.4 |  |  | $ | 221.9 |
(In millions) | April 30, 2020 |  | October 31, 2019
Total identifiable assets: |  |  |
CooperVision | $ | 4,140.3 |  |  | $ | 3,911.6 |
CooperSurgical | 2,207.4 |  |  | 2,189.8 |
Corporate | 162.2 |  |  | 173.1 |
Total | $ | 6,510.0 |  |  | $ | 6,274.5 |
Geographic information:
Periods Ended April 30, | Three Months |  | Six Months
(In millions) | 2020 |  | 2019 |  | 2020 |  | 2019
Net sales to unaffiliated customers by country of domicile: |  |  |  |  |  |  |
United States | $ | 222.5 |  |  | $ | 305.9 |  |  | $ | 516.0 |  |  | $ | 584.9 |
Europe | 178.8 |  |  | 209.5 |  |  | 392.1 |  |  | 419.2 |
Rest of world | 123.7 |  |  | 138.9 |  |  | 263.0 |  |  | 278.3 |
Total | $ | 524.9 |  |  | $ | 654.3 |  |  | $ | 1,171.1 |  |  | $ | 1,282.4 |
(In millions) | April 30, 2020 |  | October 31, 2019
Net property, plant and equipment by country of domicile: |  |  |
United States | $ | 674.4 |  |  | $ | 626.5 |
Europe | 354.3 |  |  | 358.8 |
Rest of world | 167.3 |  |  | 146.8 |
Total | $ | 1,196.1 |  |  | $ | 1,132.1 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration